Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Pohl

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|August 11, 2016
Key workers deserve betterEsther Pohl
Journal of Neuroscience Research|March 6, 2007
Embryonic stem cells produce neurotrophins in response to cerebral tissue extract: Cell line-dependent differencesKristine Bentz, Marek Molcanyi, Peter Riess, et al.
Human Genetics|July 16, 2013
A hypofunctional PAX1 mutation causes autosomal recessively inherited otofaciocervical syndromeEsther Pohl, Ayca Aykut, Filippo Beleggia, et al.
Human Genetics|August 29, 2013
The missing "link": an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutationJulia Schreml, Burak Durmaz, Ozgur Cogulu, et al.
Molecular Genetics & Genomic Medicine|October 6, 2015
Mutations in CDK5RAP2 cause Seckel syndromeGökhan Yigit, Karen E Brown, Hülya Kayserili, et al.
American Journal of Human Genetics|February 23, 2010
Mutations in TPRN cause a progressive form of autosomal-recessive nonsyndromic hearing lossYun Li, Esther Pohl, Redouane Boulouiz, et al.
Human Mutation|September 15, 2018
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trialKonstantin Weber-Lassalle, Philipp Harter, Jan Hauke, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2021
Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancerAndreas Schneeweiss, Laura L Michel, Volker Möbus, et al.
American Journal of Human Genetics|April 10, 2012
Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafishP V Asharani, Katharina Keupp, Oliver Semler, et al.
Journal of the National Cancer Institute|December 28, 2021
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian CancerKonstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|August 11, 2016
Key workers deserve betterEsther Pohl
Journal of Neuroscience Research|March 6, 2007
Embryonic stem cells produce neurotrophins in response to cerebral tissue extract: Cell line-dependent differencesKristine Bentz, Marek Molcanyi, Peter Riess, et al.
Human Genetics|July 16, 2013
A hypofunctional PAX1 mutation causes autosomal recessively inherited otofaciocervical syndromeEsther Pohl, Ayca Aykut, Filippo Beleggia, et al.
Human Genetics|August 29, 2013
The missing "link": an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutationJulia Schreml, Burak Durmaz, Ozgur Cogulu, et al.
Molecular Genetics & Genomic Medicine|October 6, 2015
Mutations in CDK5RAP2 cause Seckel syndromeGökhan Yigit, Karen E Brown, Hülya Kayserili, et al.
American Journal of Human Genetics|February 23, 2010
Mutations in TPRN cause a progressive form of autosomal-recessive nonsyndromic hearing lossYun Li, Esther Pohl, Redouane Boulouiz, et al.
Human Mutation|September 15, 2018
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trialKonstantin Weber-Lassalle, Philipp Harter, Jan Hauke, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2021
Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancerAndreas Schneeweiss, Laura L Michel, Volker Möbus, et al.
American Journal of Human Genetics|April 10, 2012
Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafishP V Asharani, Katharina Keupp, Oliver Semler, et al.
Journal of the National Cancer Institute|December 28, 2021
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian CancerKonstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, et al.
Pageof 3